{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:07:01Z","timestamp":1786115221763,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372779"],"award-info":[{"award-number":["82372779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103001"],"award-info":[{"award-number":["82103001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472983"],"award-info":[{"award-number":["82472983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer stem cells (CSC) and the immunosuppressive microenvironments are key drivers of breast cancer (BC) progression and drug resistance. However, the molecular mechanisms by which One Cut Homeobox 2 (ONECUT2) governs CSC and the tumor immune microenvironment (TIME) remain largely unknown. Given the critical knowledge gap, we sought to investigate ONECUT2\u2019s regulatory impact on CSC properties and TIME profiles using BC cell lines, animal models, and clinical specimens. Here, we demonstrated that inhibition of ONECUT2, a core transcription factor, potently drives CSC characteristics and reprograms the TIME to favor macrophage polarization to the M2-type, a tumor-promoting state. Mechanistically, ONECUT2 inhibition transcriptionally activated POU6F2, which subsequently triggered beta-catenin, thereby enhancing CSC properties and chemoresistance in BC. With respect to modulating the immune microenvironment, suppression of ONECUT2 governs macrophage polarization toward the immunosuppressive M2 phenotype. CCL28 is identified as a transcriptional target of ONECUT2 required for M2-type macrophage polarization, and CCR10 as a key receptor involved in this immune modulation. These findings highlight the critical involvement of ONECUT2 in modulating BC stemness via targeting the POU6F2-beta-catenin axis and managing macrophage polarization to M2 phenotype through the CCL28-CCR10 pathway. Our study suggests that ONECUT2 modulates cancer stemness and the TIME, and that targeting its downstream POU6F2-beta-catenin axis and CCL28-CCR10 pathway may provide an effective approach for BC treatment.<\/jats:p>","DOI":"10.1038\/s41419-026-08909-5","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:42:57Z","timestamp":1780418577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low expression of ONECUT2 governs the POU6F2-beta-catenin axis to modulate cancer stemness and drives the CCL28-dependent pathway for macrophage polarization in breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Meng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7820-4852","authenticated-orcid":false,"given":"Ziqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-4617","authenticated-orcid":false,"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-2049","authenticated-orcid":false,"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"8909_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"8909_CR2","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1158\/0008-5472.CAN-18-4055","volume":"79","author":"M Shen","year":"2019","unstructured":"Shen M, Dong C, Ruan X, Yan W, Cao M, Pizzo D, et al. Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2. Cancer Res. 2019;79:3608\u201321.","journal-title":"Cancer Res"},{"key":"8909_CR3","doi-asserted-by":"publisher","first-page":"E4086","DOI":"10.1073\/pnas.1405354111","volume":"111","author":"D Sapkota","year":"2014","unstructured":"Sapkota D, Chintala H, Wu F, Fliesler SJ, Hu Z, Mu X. Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. Proc Natl Acad Sci USA. 2014;111:E4086\u2013E95.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8909_CR4","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1177\/15353702211038496","volume":"246","author":"C Shen","year":"2021","unstructured":"Shen C, Wang J, Xu Z, Zhang L, Gu W, Zhou X. ONECUT2 which is targeted by hsa-miR-15a-5p enhances stemness maintenance of gastric cancer stem cells. Exp Biol Med. 2021;246:2645\u201359.","journal-title":"Exp Biol Med"},{"key":"8909_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08133-6","volume":"10","author":"H Guo","year":"2019","unstructured":"Guo H, Ci X, Ahmed M, Hua JT, Soares F, Lin D, et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nat Commun. 2019;10:278.","journal-title":"Nat Commun"},{"key":"8909_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13402-024-00957-3","volume":"48","author":"I Zamora","year":"2025","unstructured":"Zamora I, Guti\u00e9rrez M, Pascual A, Pajares MJ, Barajas M, Perez LM, et al. ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity. Cell Oncol. 2025;48:83\u201399.","journal-title":"Cell Oncol"},{"key":"8909_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06885-2","volume":"15","author":"M Lin","year":"2024","unstructured":"Lin M, Tu R-H, Wu S-Z, Zhong Q, Weng K, Wu Y-K, et al. Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway. Cell Death Dis. 2024;15:497.","journal-title":"Cell Death Dis"},{"key":"8909_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101200","volume":"79","author":"X Fan","year":"2025","unstructured":"Fan X, Han F, Wang H, Shu Z, Qiu B, Zeng F, et al. YTHDF2-mediated m6A modification of ONECUT2 promotes stemness and oxaliplatin resistance in gastric cancer through transcriptionally activating TFPI. Drug Resist Updat. 2025;79:101200.","journal-title":"Drug Resist Updat"},{"key":"8909_CR9","doi-asserted-by":"publisher","first-page":"9849","DOI":"10.2147\/OTT.S227995","volume":"12","author":"J Hu","year":"2019","unstructured":"Hu J, Chen Y, Li X, Miao H, Li R, Chen D, et al. THUMPD3-AS1 is correlated with non-small cell lung cancer and regulates self-renewal through miR-543 And ONECUT2. Onco Targets Ther. 2019;12:9849\u201360.","journal-title":"Onco Targets Ther"},{"key":"8909_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","volume":"8","author":"R Zhang","year":"2023","unstructured":"Zhang R, Dong M, Tu J, Li F, Deng Q, Xu J, et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct Target Ther. 2023;8:97.","journal-title":"Signal Transduct Target Ther"},{"key":"8909_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong P-P, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31:1101\u201312.","journal-title":"Cell Stem Cell"},{"key":"8909_CR12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-23-2390","volume":"84","author":"L Yan","year":"2024","unstructured":"Yan L, Wu M, Wang T, Yuan H, Zhang X, Zhang H, et al. Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion. Cancer Res. 2024;84:1270\u201385.","journal-title":"Cancer Res"},{"key":"8909_CR13","doi-asserted-by":"crossref","unstructured":"Erickson HL, Taniguchi S, Raman A, Leitenberger JJ, Malhotra SV, Oshimori N. Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Immunity. 2024;57:1908-22.e6.","DOI":"10.1016\/j.immuni.2024.07.004"},{"key":"8909_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413019","volume":"12","author":"G Zhang","year":"2025","unstructured":"Zhang G, Zhang X, Pan W, Chen X, Wan L, Liu C, et al. Dissecting the spatial and single-cell transcriptomic architecture of cancer stem cell niche driving tumor progression in gastric cancer. Adv Sci. 2025;12:e2413019.","journal-title":"Adv Sci"},{"key":"8909_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","volume":"7","author":"S Raghavan","year":"2019","unstructured":"Raghavan S, Mehta P, Xie Y, Lei YL, Mehta G. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. J Immunother Cancer. 2019;7:190.","journal-title":"J Immunother Cancer"},{"key":"8909_CR16","doi-asserted-by":"crossref","unstructured":"Gu D, Hu L, Yang K, Yuan W, Shan D, Gao J, et al. Stress-induced pro-inflammatory glioblastoma stem cells secrete TNFAIP6 to enhance tumor growth and induce suppressive macrophages. Dev Cell. 2025;60:2558-75.e6.","DOI":"10.1016\/j.devcel.2025.04.027"},{"key":"8909_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7150\/ijbs.86085","volume":"20","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang L, Zhao L, Shao S, Ning Q, Jing X, et al. VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk. Int J Biol Sci. 2024;20:446\u201363.","journal-title":"Int J Biol Sci"},{"key":"8909_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.854724","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhang Q, Tu K, Chen Y, Peng Y, Ni Y, et al. Single-cell transcriptomics of immune cells reveal diversity and exhaustion signatures in non-small-cell lung cancer. Front Immunol. 2022;13:854724.","journal-title":"Front Immunol"},{"key":"8909_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/gene.2008.18","volume":"9","author":"K Furuno","year":"2008","unstructured":"Furuno K, Ikeda K, Hamano S, Fukuyama K, Sonoda M, Hara T, et al. Onecut transcription factor OC2 is a direct target of T-bet in type-1 T-helper cells. Genes Immun. 2008;9:302\u20138.","journal-title":"Genes Immun"},{"key":"8909_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1413520","volume":"7","author":"M Shen","year":"2018","unstructured":"Shen M, Wang J, Yu W, Zhang C, Liu M, Wang K, et al. A novel MDSC-induced PD-1-PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties. Oncoimmunology. 2018;7:e1413520.","journal-title":"Oncoimmunology"},{"key":"8909_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41580-024-00823-y","volume":"26","author":"MM Maurice","year":"2025","unstructured":"Maurice MM, Angers S. Mechanistic insights into Wnt-\u03b2-catenin pathway activation and signal transduction. Nat Rev Mol Cell Biol. 2025;26:371\u201388.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8909_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21:526\u201336.","journal-title":"Nat Rev Cancer"},{"key":"8909_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01748-4","volume":"22","author":"B Wu","year":"2023","unstructured":"Wu B, Shi X, Jiang M, Liu H. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. Mol Cancer. 2023;22:38.","journal-title":"Mol Cancer"},{"key":"8909_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3892\/or.2017.5798","volume":"38","author":"X Yang","year":"2017","unstructured":"Yang X, Liu K, Lin F, Shi H, Ou Z. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis. Oncol Rep. 2017;38:1393\u2013401.","journal-title":"Oncol Rep"},{"key":"8909_CR25","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.2147\/CMAR.S256316","volume":"12","author":"J Chen","year":"2020","unstructured":"Chen J, Chen J, Sun B, Wu J, Du C. ONECUT2 accelerates tumor proliferation through activating ROCK1 expression in gastric cancer. Cancer Manag Res. 2020;12:6113\u201321.","journal-title":"Cancer Manag Res"},{"key":"8909_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56277-2","volume":"9","author":"Q Ma","year":"2019","unstructured":"Ma Q, Wu K, Li H, Li H, Zhu Y, Hu G, et al. ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression. Sci Rep. 2019;9:20021.","journal-title":"Sci Rep"},{"key":"8909_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04410-3","volume":"12","author":"D Liu","year":"2021","unstructured":"Liu D, Zhang T, Chen X, Zhang B, Wang Y, Xie M, et al. ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. Cell Death Dis. 2021;12:1113.","journal-title":"Cell Death Dis"},{"key":"8909_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17:46.","journal-title":"J Hematol Oncol"},{"key":"8909_CR29","first-page":"507","volume":"10","author":"Y Xu","year":"2024","unstructured":"Xu Y, Yu Y, Yan R, Ke X, Qu Y. Modulating \u03b2-catenin homeostasis for cancer therapy. Trends Cancer. 2024;10:507\u201318.","journal-title":"Trends Cancer"},{"key":"8909_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/MPH.0b013e31802d3e65","volume":"28","author":"F Di Renzo","year":"2006","unstructured":"Di Renzo F, Doneda L, Menegola E, Sardella M, De Vecchi G, Collini P, et al. The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors. J Pediatr Hematol Oncol. 2006;28:791\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"8909_CR31","doi-asserted-by":"publisher","first-page":"e1007145","DOI":"10.1371\/journal.pgen.1007145","volume":"14","author":"R King","year":"2018","unstructured":"King R, Struebing FL, Li Y, Wang J, Koch AA, Cooke Bailey JN, et al. Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing glaucoma. PLoS Genet. 2018;14:e1007145.","journal-title":"PLoS Genet"},{"key":"8909_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41416-025-03017-1","volume":"133","author":"C Yang","year":"2025","unstructured":"Yang C, Gao Z, Tang R, Zhou L, Zhou P, Shi W, et al. POU6F2 promotes liver metastasis of gastric adenocarcinoma by dual mechanism of transcriptional upregulation of SNAI1 and IGF2\/PI3K\/AKT signaling-induced conversion of hepatic stellate cells into cancer-associated fibroblasts. Br J Cancer. 2025;133:14\u201326.","journal-title":"Br J Cancer"},{"key":"8909_CR33","doi-asserted-by":"crossref","unstructured":"Hong B, Zhang X, Du X, Yang D, Hu Z, Zhang X, et al. Exploring the potential driver gene mutations that promote renal cancer cell metastasis and implantation based on circulating tumor cells culture. Diagnostics. 2023;13:1855.","DOI":"10.3390\/diagnostics13111855"},{"key":"8909_CR34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/humu.20096","volume":"24","author":"D Perotti","year":"2004","unstructured":"Perotti D, De Vecchi G, Testi MA, Lualdi E, Modena P, Mondini P, et al. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14. Hum Mutat. 2004;24:400\u20137.","journal-title":"Hum Mutat"},{"key":"8909_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1022","volume":"7","author":"Y Miao","year":"2019","unstructured":"Miao Y, Li C, Guo J, Wang H, Gong L, Xie W, et al. Identification of a novel somatic mutation of POU6F2 by whole-genome sequencing in prolactinoma. Mol Genet Genom Med. 2019;7:e1022.","journal-title":"Mol Genet Genom Med"},{"key":"8909_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41575-025-01127-y","volume":"23","author":"BM Lehrich","year":"2026","unstructured":"Lehrich BM, Monga SP. WNT-\u03b2-catenin signalling in hepatocellular carcinoma: from bench to clinical trials. Nat Rev Gastroenterol Hepatol. 2026;23:246\u201363.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8909_CR37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.7150\/thno.87962","volume":"14","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Tsui Y-M, Zhang VX, Lu AJ, Lee JM-F, Lee E, et al. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. Theranostics. 2024;14:892\u2013910.","journal-title":"Theranostics"},{"key":"8909_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-024-00550-2","volume":"13","author":"W Chen","year":"2024","unstructured":"Chen W, Chen M, Hong L, Xiahenazi A, Huang M, Tang N, et al. M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. Exp Hematol Oncol. 2024;13:83.","journal-title":"Exp Hematol Oncol"},{"key":"8909_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06383-x","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shen Y, Zhang Q, Feng X, Liu X, Huo X, et al. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer. Cell Death Dis. 2023;14:850.","journal-title":"Cell Death Dis"},{"key":"8909_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217642","volume":"618","author":"M Zhou","year":"2025","unstructured":"Zhou M, Guan B, Liu Y, Gu Q, Chen W, Xie B, et al. Fibrinogen-like 2 in tumor-associated macrophage-derived extracellular vesicles shapes an immunosuppressive microenvironment in colorectal liver metastases by promoting tumor stemness and neutrophil extracellular traps formation. Cancer Lett. 2025;618:217642.","journal-title":"Cancer Lett"},{"key":"8909_CR41","doi-asserted-by":"crossref","unstructured":"Zhu, Y et al. Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell. 2025;43:232\u2013246.","DOI":"10.1016\/j.ccell.2025.03.015"},{"key":"8909_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01990-4","volume":"23","author":"M Kundu","year":"2024","unstructured":"Kundu M, Butti R, Panda VK, Malhotra D, Das S, Mitra T, et al. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer. 2024;23:92.","journal-title":"Mol Cancer"},{"key":"8909_CR43","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1158\/0008-5472.CAN-19-3074","volume":"80","author":"L Ji","year":"2020","unstructured":"Ji L, Qian W, Gui L, Ji Z, Yin P, Lin GN, et al. Blockade of \u03b2-catenin-induced CCL28 suppresses gastric cancer progression via inhibition of Treg cell infiltration. Cancer Res. 2020;80:2004\u201316.","journal-title":"Cancer Res"},{"key":"8909_CR44","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1172\/JCI125336","volume":"129","author":"J Park","year":"2019","unstructured":"Park J, Zhang X, Lee SK, Song N-Y, Son SH, Kim KR, et al. CCL28-induced RAR\u03b2 expression inhibits oral squamous cell carcinoma bone invasion. J Clin Invest. 2019;129:5381\u201399.","journal-title":"J Clin Invest"},{"key":"8909_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01896-7","volume":"22","author":"MSB Masroni","year":"2023","unstructured":"Masroni MSB, Lee KW, Lee VKM, Ng SB, Law CT, Poon KS, et al. Dynamic altruistic cooperation within breast tumors. Mol Cancer. 2023;22:206.","journal-title":"Mol Cancer"},{"key":"8909_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101842","volume":"40","author":"S Li","year":"2024","unstructured":"Li S, Zhang N, Yang Y, Liu T. Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells. Transl Oncol. 2024;40:101842.","journal-title":"Transl Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08909-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:45:39Z","timestamp":1785977139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08909-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8909"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08909-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"690"}}